Samuel Pearce, Julian T Maingard, Kenny Li, Hong Kuan Kok, Christen D Barras, Jeremy H Russell, Joshua A Hirsch, Ronil V Chandra, Ash Jhamb, Vincent Thijs, Mark Brooks, Hamed Asadi
Clinical neuroradiology 2020 SepThe development of endovascular treatment for intracranial aneurysms has established new techniques such as balloon and stent-assistance, flow diversion and endosaccular occlusion devices. Antiplatelet treatment is an important aspect to reduce risk of thrombus formation on microcatheters and implanted devices when utilizing these methods. It is particularly relevant for flow diverting stents to prevent early and late stent thrombosis. Consideration of platelet physiology and appropriate selection of antiplatelet medication is important as platelet dysfunction drives many of the pathological processes and complications of neurointerventional procedures. Part one of this review focuses on basic platelet physiology, pharmacology of common antiplatelet medications and future directions and therapies. Part two focuses on clinical applications and evidence-based therapeutic regimens.
Samuel Pearce, Julian T Maingard, Kenny Li, Hong Kuan Kok, Christen D Barras, Jeremy H Russell, Joshua A Hirsch, Ronil V Chandra, Ash Jhamb, Vincent Thijs, Mark Brooks, Hamed Asadi. Antiplatelet Drugs for Neurointerventions: Part 1 Clinical Pharmacology. Clinical neuroradiology. 2020 Sep;30(3):425-433
PMID: 32424668
View Full Text